American Medical Innovation and Investment Act of 2024

This bill requires Medicare to include cognitive impairment screening using specific tools during annual wellness visits and initial preventive exams starting in 2025, documenting results in patient records. It also expands Medicare coverage for external infusion pumps and home infusion drugs under defined safety and administration criteria, effective after 2025. Additionally, the bill mandates future guidance for Medicare payment on AI-enabled remote monitoring devices and prescription digital therapeutics, with reports to Congress on coverage authority. These changes directly affect Medicare beneficiaries, healthcare providers, and home infusion therapy suppliers by modifying coverage rules and documentation requirements.